| e. marginatum | acute rheumatic fever |
| LEOPARD sx | EKG abnormality |
| neonatal LE | complete heart block |
| tuberous sclerosis | cardiac rhabdomyoma |
| Carney complex | atrial myxomas |
| leishmania | cardiac monitor during antimony treatment |
| Kawasaki syndrome | coronary artery aneurysms |
| amyloid | restrictive cardiac myopathy |
| acne | erythromycin treatment increases digoxin level |
| hypereosinophilic syndrome | cardiac disease is the most frequent systemic complication (presenting as failure or arrhythmias) and the most common cause of morbidity and mortality |
| Churg-Strauss syndrome | major cause of mortality = cardiac failure (granulomatous infiltration of the myocardium resulting in restrictive cardiomyopathy, and coronary artery vasculitis causing MI are both described) |
| Ehlers-Danlos | mitral valve prolapse (types I, II, III) |
| Ehlers-Danlos (type IV) | aneurysm, dissection, rupture of large and medium size vessels |
| Cutis Laxa | aortic disease may be present as a result of aortic vessel medial degeneration and extracellular elastin deposits lacking microfibrillar elements |
| Marfan syndrome | progressive aneurysmal dilatation of ascending aorta (with secondary regurgitation, CHF, dissection and rupture); mitral valve prolapse |
| PXE | (degeneration of elastic fibers in vessel media; calcification of peripheral arterites) mitral valve prolapse, CAD, PVD, HTN |
| subacute bacterial endocarditis | splinter hemorrhage, Janeway lesions, Oslers nodes, septic vasculitis |
| anticoagulated patient | coumadin necrosis (heparin also) |
| lupus | pericarditis?, Liebman-Sachs ??? |
| xanthomas | familial hyperlipidemias, athersclerotic heart disease |
| beta-blockers (anti-hypertensives, | hair loss |
anti-coagulants)
| ACE inhibitors | angioedema |
| procainamide | drug-LE (but no skin lesions ??) |
| phenol peel | cardiac toxicity |
|